image: Prof. Douglas Wallace will join Targeting Mitochondria 2022 as a keynote speaker view more
Credit: Credits to the World Mitochondria Society
Berlin will host Targeting Mitochondria 2022 with more than 210 participants coming from 34 countries. More than 130 communications will be presented during 3 days. Industrial Attendees are well represented this year.
Among Industrials who will take part:
Astellas Pharma Inc, AbbVie, Beiersdorf, LUCA Science Inc., Kyowa Kirin Co., MitoImmune Therapeutics Inc., Amazentis, Thermo Fisher Scientific, H. Lundbeck A/S, UCB Bio Pharma, PuREC Co., Cellergy, Nestlé, OMEICOS Therapeutics GmbH, 4BIO Capital, PAEAN Biotechnology, mse Pharmazeutika GmbH, MitoImmune Therapeutics Inc., Defence Science and Technology Laboratory and others.
For access to the full list of academics and others, please click here.
Mitochondrial medicine will be strongly discussed and the slogan of Targeting Mitochondria 2022 is “the future of medicine will come through mitochondria”.
Among the strategic topics which will be presented during Targeting Mitochondria:
Mitochondrial Signaling, Mitochondrial Diseases, Cancer, Cardiovascular Diseases (Stroke), Sepsis, Fatty Liver Disease, Respiratory Diseases, Schizophrenia, Brain Injury and Neurological Diseases, Ageing, Gene/metabolic Disorders, Extracellular Vesicles and Mitochondrial Dysfunctions, Extracellular Vesicles Therapy, Mitochondrial Medicine, Mitochondrial Transplantation, Mitochondrial Transfer, Mitochondrial Genome Engineering, Translational Therapy, Photo-medicine, Infrared Light, Mitochondria and Vision…
|